Affiliation
Royal College of Surgeons in Ireland Dublin, Ireland and. Beaumont Hospital Dublin, Ireland.Issue Date
2021-09-21
Metadata
Show full item recordPublisher
the American Thoracic SocietyJournal
American journal of respiratory and critical care medicineDOI
10.1164/rccm.202008-3169LEPubMed ID
32955924PubMed Central ID
PMC7781117Abstract
Reply to Blot et al. and to Inoue et al. From the Authors: We thank Blot and colleagues for their interest in our article and for raising an important question regarding the suitability of IL-6 as a therapeutic target in coronavirus disease (COVID-19). In their correspondence, Blot and colleagues provide data on IL-6 levels measured in patients with a diagnosis of COVID-19 versus non–COVID-19 pneumonia. Although we believe the data presented by Blot and colleagues are valid, we suggest that the IL-6 levels depicted are, by virtue of sample timing, processing methodology, and patient severity of disease, not comparable to ours and should be interpreted in context.Item Type
OtherLanguage
enSeries/Report no.
2021 Jan 1;203(1):141-142EISSN
1535-4970ae974a485f413a2113503eed53cd6c53
10.1164/rccm.202008-3169LE